Oral Answers to Questions

Kate Osamor Excerpts

Tuesday 22nd July 2025 Commons Chamber

[Karin Smyth]

The hon. Member highlights the importance of getting this right not only from hospital to discharge but, crucially, in primary care, where 90% of patient contacts happen across the system. That is why a central plank of our 10-year plan has been moving the entire system from the analogue to the digital age. We have allocated £10 billion, particularly in this spending review, to address this issue and make sure we get this right for the system and for patients.

[Kate Osamor (Edmonton and Winchmore Hill) (Lab/Co-op)]

8. What assessment he has made of the potential impact of the 10-year health plan for England on the prevention of ill health.

[The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)]

The 10-year health plan sets out how we are transforming our approach to preventing ill health through a set of ambitious measures that make the healthy choice the easy choice. Among those measures is our mandatory partnership with food businesses, through which we will make shopping baskets across the country healthier, and our landmark Tobacco and Vapes Bill, to help deliver our ambition for a smoke-free UK by gradually ending the sale of tobacco products across the country.

[Kate Osamor]

I thank the Minister for her response. Sickle cell disease disproportionately affects people from African and Caribbean backgrounds, yet systematic inequalities persist. A recent NHS Race and Health Observatory report reveals that research funding for cystic fibrosis is 2.5 times higher, despite similar prevalence. Will the Minister commit to addressing the chronic underfunding and ensure equitable investment in research and workforce specialist training for sickle cell patients across the NHS?

[Ashley Dalton]

The Government are committed to addressing health inequalities experienced by people living with rare conditions such as sickle cell disorder. Pioneering research is a cross-cutting theme of the UK rare diseases framework, but we know that there are a small number of rare conditions with a large amount of research, while many more have little or no funded research. I want to confirm for my hon. Friend that the National Institute for Health and Care Research welcomes funding applications for research into all and any aspects of health or care, including sickle cell disorder.